Literature DB >> 19744171

RUNX2 mutations in cleidocranial dysplasia patients.

H-M Ryoo1, H-Y Kang, S-K Lee, K-E Lee, J-W Kim.   

Abstract

OBJECTIVE: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified in cleidocranial dysplasia (CCD) patients. CCD is a rare autosomal-dominant disease characterized by the delayed closure of cranial sutures, defects in clavicle formation, and supernumerary teeth. The purposes of this study were to identify genetic causes of two CCD nuclear families and to report their clinical phenotypes.
MATERIALS AND METHODS: We identified two CCD nuclear families and performed mutational analyses to clarify the underlying molecular genetic etiology.
RESULTS: Mutational analysis revealed a novel nonsense mutation (c.273T>A, p.L93X) in family 1 and a de novo missense one (c.673C>T, p.R225W) in family 2. Individuals with a nonsense mutation showed maxillary hypoplasia, delayed eruption, multiple supernumerary teeth, and normal stature. In contrast, an individual with a de novo missense mutation in the Runt domain showed only one supernumerary tooth and short stature.
CONCLUSIONS: Mutational and phenotypic analyses showed that the severity of mutations on the skeletal system may not necessarily correlate with that of the disruption of tooth development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744171     DOI: 10.1111/j.1601-0825.2009.01623.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  13 in total

Review 1.  Aetiology of supernumerary teeth: a literature review.

Authors:  R P Anthonappa; N M King; A B M Rabie
Journal:  Eur Arch Paediatr Dent       Date:  2013-09-26

2.  A novel Alu-mediated microdeletion in the RUNX2 gene in a Chinese patient with cleidocranial dysplasia.

Authors:  Yunzhu Qian; Yingying Zhang; Bin Wei; Mengshu Zhang; Jianxin Yang; Cuihua Leng; Zili Ge; Xingshun Xu; Miao Sun
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

3.  Characterization of dental phenotype in patients with cleidocranial dysplasia using longitudinal data.

Authors:  Sang-Woon Ha; Yu-Jin Jung; Han-Sol Bae; Hyun-Mo Ryoo; Il-Sik Cho; Seung-Hak Baek
Journal:  Angle Orthod       Date:  2018-04-17       Impact factor: 2.079

4.  The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.

Authors:  Min-Su Han; Hyo-Jin Kim; Hee-Jun Wee; Kyung-Eun Lim; Na-Rae Park; Suk-Chul Bae; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Je-Yong Choi
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

Review 5.  Molecular genetics of supernumerary tooth formation.

Authors:  Xiu-Ping Wang; Jiabing Fan
Journal:  Genesis       Date:  2011-04-01       Impact factor: 2.487

6.  A novel gene mutation of Runx2 in cleidocranial dysplasia.

Authors:  You-Jian Peng; Qiao-Yun Chen; Dong-Jie Fu; Zhi-Ming Liu; Tian-Tian Mao; Jun Li; Wen-Ting She
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

7.  Cleidocranial dysplasia syndrome (CCD) with an unusual finding in a young patient.

Authors:  Parul Singhal; Anita Singhal; Cheranjeevi Jayam; Anila Bandlapalli
Journal:  BMJ Case Rep       Date:  2015-11-18

8.  Novel Mutation of Cleidocranial Dysplasia-related Frameshift Runt-related Transcription Factor 2 in a Sporadic Chinese Case.

Authors:  Xue-Yan Qin; Pei-Zeng Jia; Hua-Xiang Zhao; Wei-Ran Li; Feng Chen; Jiu-Xiang Lin
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

9.  Cleidocranial dysplasia with hearing loss.

Authors:  Ramesh Candamourty; Suresh Venkatachalam; Vaithilingam Yuvaraj; Ganesan Suresh Kumar
Journal:  J Nat Sci Biol Med       Date:  2013-01

10.  Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis.

Authors:  Huaiguang Chang; Yue Wang; Haochen Liu; Xu Nan; Singwai Wong; Saihui Peng; Yajuan Gu; Hongshan Zhao; Hailan Feng
Journal:  Cell Death Dis       Date:  2017-12-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.